Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...

Off-label prescribing has entered standard treatments and is at the cutting edge of medical innovation, but it carries ...

The entertainment news features NewJeans' legal battle with their label in South Korea, Gerard Depardieu's upcoming trial ...

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.

Open-label placebo yielded very modest analgesia in chronic low back pain, with better short- vs long-term outcomes.

Angel Del Villar is expected to face testimony from his former label star Gerardo Ortiz, who prosecutors say took a plea deal ...

The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...

Mase announces triple album release on May 5 coinciding with Diddy's trial, collaborating with Cam'ron in what appears to be ...

Medera announced that the independent Data and Safety Monitoring Board has completed its planned review of the MUSIC-HFrEF Phase 1b/2 clinical ...

Limp Bizkit’s $200 million lawsuit against Universal Music will head to trial after a federal judge denied the label’s motion ...

Thanks to a loophole in the Federal Food, Drug, and Cosmetic Act of 1938, some of the “drugs” you can buy at pharmacies are ...